Personal Statement
Mark Emberton has demonstrated an ability to achieve clinical innovation resulting in measurable clinical benefit on a number of occasions. In each of these large team efforts the results have been embraced by international clinical practice guidelines and have changed practice. The areas of innovation include the management of BPH using a self-management programme in order to reduce drug utilisation; the development of prostate MRI which has transformed the prostate cancer diagnostic pathway and, most recently, the development of minimally invasive treatments for men with prostate cancer that avoid the side-effect associated with standard whole gland treatments.